(PharmaNewsWire.Com, July 20, 2017 ) Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. The nuclear medicine equipment market is expected to grow at a single-digit CAGR in the next five years. This market is poised to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, at a CAGR of 3.6% during the forecast period. <||>rnhttp://www.marketsandmarkets.com/Market-Reports/nuclear-medicine-equipment-market-242495651.html
The nuclear medicine equipment market is segmented on the basis of product, application, and end user. The market by product is segmented into hybrid PET, SPECT, and planar scintigraphy systems. The SPECT product segment is further divided into hybrid SPECT and standalone SPECT. On the basis of application, the market is segmented into oncology, cardiology, neurology and other applications which includes orthopedics, urology, thyroid related disorders, and gastroenterology. Based on the end users the market is divided into hospitals, imaging centers, academic and research institutes and others which include pharma/biotech companies and CROs. Rising prevalence/incidence of cancer, cardiac disorders, and neurological disorders; growing awareness about the importance of early diagnosis of diseases; launch of advanced nuclear medicine equipment in the market; and rising adoption of nuclear medicine equipment by end users are major factors driving this market. However, high cost of nuclear medicine equipment and shorter half-life of radiopharmaceuticals are expected to restrain the growth of the market. In addition, growing adoption of refurbished diagnostic imaging systems and hospital budget cuts acts as a challenge for the market. On the other hand, strong product pipeline coupled with expansion & penetration opportunities in emerging economies are expected to be lucrative opportunities for the market.
Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthcare (Germany), Digirad Corporation (U.S.), Mediso Medical Imaging Systems, Ltd. (Hungary), Toshiba Medical Systems Corporation (Japan), DDD-Diagnostics A/S (Denmark), Neusoft Medical Systems Co. Ltd. (China), and SurgicEye GmbH (Germany), CMR Naviscan Corporation (U.S.).
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
